WUXIF (Wuxi AppTec Co) Short Ratio


WUXIF Wuxi AppTec Co Ltd WUXIF
84 GF Score
Price $20.58
GF Value $14.85
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Wuxi AppTec Co Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

WUXIF
84GF Score
Wuxi AppTec Co Ltd WUXIF
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Wuxi AppTec Co (WUXIF) Overvalued in 2026?

Based on GuruFocus' analysis, Wuxi AppTec Co stock appears to be overvalued. The current stock price of $20.58 is trading 38.6% above its estimated GF Value™ of $14.85. GuruFocus considers Wuxi AppTec Co to be Significantly Overvalued.

Key valuation signals for WUXIF:

  • Short Ratio:
  • GF Value™: $14.85 vs. price of $20.58 (38.6% above fair value)
  • GF Score™: 84/100 with 4 warning signs

No single metric tells the full story. See the WUXIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Wuxi AppTec Co Business Description

Address 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, CHN, 200131
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by PRC, Europe, and other regions.
84GF Score

Get the complete analysis for WUXIF

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.58
Price
$14.85
GF Value